Player FMアプリでオフラインにしPlayer FMう!
Applying Advances in Cell Cycle Biology to Inhibit CDK2 and CDK9 to Overcome Resistance to Anti-Cancer Therapies with Spiro Rombotis Cyclacel Pharmaceuticals
Manage episode 273355903 series 99915
Spiro Rombotis, President and Chief Executive Officer, Cyclacel Pharmaceuticals dives into the insights about cell cycle check point control that have led to the development of fadraciclib, a potent orally and intravenously available inhibitor of CDK2 and CDK9 cancer pathways. Drawing on the vision of the company's founding scientist, Professor Sir David Lane, the mission of Cyclacel is to provide cancer patients with a treatment that allows them to live with their cancer and not die from it.
#Cyclacel #fadra #cancer #solidtumors
1725 つのエピソード
Manage episode 273355903 series 99915
Spiro Rombotis, President and Chief Executive Officer, Cyclacel Pharmaceuticals dives into the insights about cell cycle check point control that have led to the development of fadraciclib, a potent orally and intravenously available inhibitor of CDK2 and CDK9 cancer pathways. Drawing on the vision of the company's founding scientist, Professor Sir David Lane, the mission of Cyclacel is to provide cancer patients with a treatment that allows them to live with their cancer and not die from it.
#Cyclacel #fadra #cancer #solidtumors
1725 つのエピソード
Alle afleveringen
×プレーヤーFMへようこそ!
Player FMは今からすぐに楽しめるために高品質のポッドキャストをウェブでスキャンしています。 これは最高のポッドキャストアプリで、Android、iPhone、そしてWebで動作します。 全ての端末で購読を同期するためにサインアップしてください。